Erik Atkisson serves as Executive at Eiger BioPharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Erik Atkisson has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 11, 2022 involved receiving (via award) 6,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 11, 2022 | EIGR | $0 | Award | 6,000 | $N/A | Discretionary |
Erik Atkisson currently holds 6,000 shares of Eiger BioPharmaceuticals, Inc. (EIGR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Erik Atkisson has been a net neutral trader of EIGR stock. They have purchased $0 and sold $0 worth of shares.
Erik Atkisson's most recent insider trade was on Mar 11, 2022, when they sold 6,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted